MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference
Is the Options Market Predicting a Spike in MiMedx Group Stock?
MiMedx: The Hard Math Behind My Downgrade To Hold
MIMEDX Announces Launch of G4Derm® Plus
Some May Be Optimistic About MiMedx Group's (NASDAQ:MDXG) Earnings
How Reimbursement Shifts Are Rewriting The MiMedx Group (MDXG) Investment Narrative
MiMedx Group, Inc. (NASDAQ:MDXG) Analysts Are Cutting Their Estimates: Here's What You Need To Know
MiMedx Group (MDXG) Launches CHORIOFIX Placental Allograft for Complex, Tunneling Wounds
Citizens Maintains Market Outperform on MiMedx Group, Lowers Price Target to $6
MiMedx Group Inc (MDXG) Q1 2026 Earnings Call Highlights: Navigating Growth and Challenges
MiMedx Group, Inc. (MDXG) Q1 2026 Earnings Call Transcript
MiMedx (MDXG) Reports Q1 Loss, Tops Revenue Estimates
MiMedx Group Q1 Earnings Call Highlights
MiMedx Group (NASDAQ:MDXG) Posts Disappointing Q1 Results, Stock Tumbles 8% After-Hours
MIMEDX Announces First Quarter 2026 Operating & Financial Results
CORRECTION: MiMedx Group Q1 Adj. EPS $(0.05) Misses $(0.03) Estimate, Sales $58.991M Miss $65.020M Estimate.
MiMedx Group Lowers FY2026 Sales Guidance from $340.000M-$360.000M to $260.000M-$290.000M vs $307.000M Est
Northland Reaffirms Outperform Rating for MiMedx Group (MDXG)
Earnings Preview: MiMedx (MDXG) Q1 Earnings Expected to Decline
MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.